Ofatumumab: a novel monoclonal anti-CD20 antibody

por Lin, Thomas S
Publicado 2010

Update in the management of chronic lymphocytic leukemia

por Maddocks, Kami J, Lin, Thomas S
Publicado 2009

What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)

por Maddocks, Kami J, Lin, Thomas S
Publicado 2009

Aci-bench: a Novel Ambient Clinical Intelligence Dataset for Benchmarking Automatic Visit Note Generation

por Yim, Wen-wai, Fu, Yujuan, Ben Abacha, Asma, Snider, Neal, Lin, Thomas, Yetisgen, Meliha
Publicado 2023

Suspect Screening of Maternal Serum to Identify New Environmental Chemical Biomonitoring Targets using Liquid Chromatography-Quadrupole Time-Of-Flight Mass Spectrometry

por Gerona, Roy R., Schwartz, Jackie M., Pan, Janet, Friesen, Matthew M., Lin, Thomas, Woodruff, Tracey J.
Publicado 2017

A Suspect Screening Method for Characterizing Multiple Chemical Exposures among a Demographically Diverse Population of Pregnant Women in San Francisco

por Wang, Aolin, Gerona, Roy R., Schwartz, Jackie M., Lin, Thomas, Sirota, Marina, Morello-Frosch, Rachel, Woodruff, Tracey J.
Publicado 2018

Gaussian graphical modeling of the serum exposome and metabolome reveals interactions between environmental chemicals and endogenous metabolites

por Bessonneau, Vincent, Gerona, Roy R., Trowbridge, Jessica, Grashow, Rachel, Lin, Thomas, Buren, Heather, Morello-Frosch, Rachel, Rudel, Ruthann A.
Publicado 2021

Integrating Exposure Knowledge and Serum Suspect Screening as a New Approach to Biomonitoring: An Application in Firefighters and Office Workers

por Grashow, Rachel, Bessonneau, Vincent, Gerona, Roy R., Wang, Aolin, Trowbridge, Jessica, Lin, Thomas, Buren, Heather, Rudel, Ruthann A., Morello-Frosch, Rachel
Publicado 2020

A Phase I/II Study of Etanercept and Rituximab in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

por Woyach, Jennifer A, Lin, Thomas S, Lucas, Margaret S, Heerema, Nyla, Moran, Mollie E., Cheney, Carolyn, Lucas, David M., Wei, Lai, Caligiuri, Michael A., Byrd, John C.
Publicado 2009

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers

por Soefje, Scott A., Carpenter, Corinne, Carlson, Katherine, Awasthi, Samir, Lin, Thomas S., Kaila, Shuchita, Tarjan, Daniel, Kayal, Nikhil, Kirkup, Christian, Wagner, Tyler E., Gray, Kathleen S., Kumar, Shaji
Publicado 2023

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

por Guinn, Daphne, Ruppert, Amy S., Maddocks, Kami, Jaglowski, Samantha, Gordon, Amber, Lin, Thomas S., Larson, Richard, Marcucci, Guido, Hertlein, Erin, Woyach, Jennifer, Johnson, Amy J., Byrd, John C.
Publicado 2014

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

por Jakubowiak, Andrzej J, Kumar, Shaji, Medhekar, Rohan, Pei, Huiling, Lefebvre, Patrick, Kaila, Shuchita, He, Jianming, Lafeuille, Marie-Hélène, Cortoos, Annelore, Londhe, Anil, Mavros, Panagiotis, Lin, Thomas S, Usmani, Saad Z
Publicado 2022

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

por Yimer, Habte, Melear, Jason, Faber, Edward, Bensinger, William I., Burke, John M., Narang, Mohit, Stevens, Don, Gunawardena, Sriya, Lutska, Yana, Qi, Keqin, Ukropec, Jon, Qi, Ming, Lin, Thomas S., Rifkin, Robert M.
Publicado 2019

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma

por Chari, Ajai, Lonial, Sagar, Mark, Tomer M., Krishnan, Amrita Y., Stockerl‐Goldstein, Keith E., Usmani, Saad Z., Londhe, Anil, Etheredge, Delores, Fleming, Sarah, Liu, Baolian, Ukropec, Jon, Lin, Thomas S., Jagannath, Sundar, Nooka, Ajay K.
Publicado 2018

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition

por Ni, Wenjun, Ji, Jia, Dai, Zunyan, Papp, Audrey, Johnson, Amy J., Ahn, Sunjoo, Farley, Katherine L., Lin, Thomas S., Dalton, James T., Li, Xiaobai, Jarjoura, David, Byrd, John C., Sadee, Wolfgang, Grever, Michael R., Phelps, Mitch A.
Publicado 2010

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

por Nooka, Ajay K., Kaufman, Jonathan L., Rodriguez, Cesar, Jakubowiak, Andrzej, Efebera, Yvonne, Reeves, Brandi, Wildes, Tanya, Holstein, Sarah A., Anderson, Larry D., Badros, Ashraf, Shune, Leyla, Chari, Ajai, Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Richardson, Paul G., Voorhees, Peter
Publicado 2022

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study

por Sborov, Douglas W., Baljevic, Muhamed, Reeves, Brandi, Laubach, Jacob, Efebera, Yvonne A., Rodriguez, Cesar, Costa, Luciano J., Chari, Ajai, Silbermann, Rebecca, Holstein, Sarah A., Anderson, Larry D., Kaufman, Jonathan L., Shah, Nina, Pei, Huiling, Patel, Sharmila, Cortoos, Annelore, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Voorhees, Peter M., Richardson, Paul G.
Publicado 2022

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia

por Raval, Aparna, Tanner, Stephan M., Byrd, John C., Angerman, Elizabeth B., Perko, James D., Chen, Shih-Shih, Hackanson, Björn, Grever, Michael R., Lucas, David M., Matkovic, Jennifer J., Lin, Thomas S., Kipps, Thomas J., Murray, Fiona, Weisenburger, Dennis, Sanger, Warren, Lynch, Jane, Watson, Patrice, Jansen, Mary, Yoshinaga, Yuko, Rosenquist, Richard, de Jong, Pieter J., Coggill, Penny, Beck, Stephan, Lynch, Henry, de la Chapelle, Albert, Plass, Christoph
Publicado 2007